News for Certara, Inc. (CERT)

We recently compiled a list of the 10 Cash-Rich Small Cap Stocks To Invest In According To Analysts. In this article, we are going to take a look at where Certara, Inc.

Small-cap stocks in the US have been under pressure, with the Russell small cap index falling 10% from its November highs as of January 2025.

**media[558459]**

Shares of Certara Inc (CERT) fell 4.52% in mid-day trading on Feb 28. The stock reached an intraday low of $11.64, before recovering slightly to $11.84, dow

Strengths: Advanced biosimulation technology and a broad customer base including top biopharmaceutical companies.Weaknesses: Intense competition and reliance o

Total Revenue: $385.1 million for the full year 2024, representing 9% growth year-over-year.Fourth Quarter Revenue: $100.4 million, a 14% increase year-over-ye

Feb 26, 2025 / 10:00PM GMTOperator Good day, and thank you for standing by. Welcome to the Certara fourth-quarter 2024 earnings conference call. (Operator Instr

Certara, Inc. (NASDAQ:CERT) Q4 2024 Earnings Conference Call February 26, 2025 5:00 PM ETCompany ParticipantsDavid Deuchler - Investor Relations, Gilmartin...

Certara (CERT) delivered earnings and revenue surprises of 15.38% and 0.68%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

The following slide deck was published by Certara, Inc.

Shares of Certara Inc (CERT) fell 4.64% in mid-day trading on Feb 25. The stock reached an intraday low of $12.47, before recovering slightly to $12.55, dow

We recently published an article titled Top 10 Health Information Services Stocks Outpacing The Market In 2025. In this article, we are going to take a look at where Certara, Inc.

Texas-based Moleculin Biotech, Inc. (MBRX), a clinical stage pharmaceutical company is up over 53 percent in Friday's pre-market trading. The following are some of the other stocks making big moves in Friday's pre-market trading.

**media[527616]**

RedHill stock rises on expanded Medicare coverage

PR NewswireRALEIGH, N.C. and TEL-AVIV, Israel, Jan. 21, 2025 Talicia is now covered by Humana's Part D Plan, providing access to Talicia for H. pylori ther

The stock of Zhongchao Inc. (ZCMD) experienced significant volatility, plunging 24.90% to $1.35 per share. The trading volume reached 21,904 shares with a turno

Certara Inc (CERT), a global leader in model-informed drug development, has released its preliminary financial results for the fourth quarter and full year of 2

Full-Year 2024 Revenue of $384.4 million, Bookings of $445.3 millionConfirms Adjusted EBITDA within Guidance Range of $120 million to $124 million RADNOR, Pa